This year's event — hosted again by Venture Partners at CU Boulder on Feb. 27 — will feature 18 startups from CU Boulder, CU Anschutz, CU Denver, University of Colorado Colorado Springs, Colorado State University, Colorado School of Mines and NIST.
Randolph, a professor in the Department of Chemical and Biological Engineering, founded VitriVax, a CU Boulder spinout, to commercialize new applications of atomic layer deposition techniques for producing thermally stable vaccines.
Inscripta, a digital genome engineering company spun out of CU Boulder research, has just raised another $125 million in a Series D financing on the heels of launching its revolutionary product, The Onyx™.
Led by its current investors Maverick Ventures and Global Frontier Investments, the funding will be used to advance the development of ColdQuanta’s cold atom Quantum Core technology, the foundation for the company’s development of quantum computers.
A 2-year, $2 million National Cancer Institute (NCI) award has been given to Boulder-based startup SuviCa, Inc. co-founded by CU Boulder and CU Cancer Center investigator, Dr. Tin Tin Su. Dr. Su hopes to find drugs that augment the effect of radiation to keep cancer at bay.
The Lab Venture Challenge is hosted over two days and broken up into Biosciences on Wednesday, Nov. 13 and Physical Sciences & Engineering on Thursday, Nov. 14. This showcase is the can't-miss event of the year to see CU Boulder's next wave of breakthrough innovations.